Board to approve September 2026 quarter and half-year results

EBITDA margin expansionResults View source PDF Explain this filing

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.8%Reaction day

₹249.45

prior close

₹249.55

announcement price

After-mkt

timing

Nifty Microcap 250market+0.4%+1.4% vs market

Biotechnology peers, median of 5sector+0.0%+1.8% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 1.8 pts more than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-1.0

15m

-0.1

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.8+0.4+1.4+0.0+1.8

Next day

+4.4+2.1+2.3+3.6+0.8

+5.0+2.2+2.8+4.7+0.3

+6.6+2.9+3.8+5.8+0.8

+4.2+0.3+3.9+5.1-0.8

+12.1+1.8+10.4+5.1+7.1

+11.4+4.2+7.1+10.4+1.0

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on October 31, 2026, to approve unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The trading window remains closed through November 2, 2026. No financial figures were disclosed.

Likely market impact

No performance figures were disclosed. The stock may react when the results are announced on October 31, 2026.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹214.5 Cr	₹184.5 Cr	+16.2%
Operating profit	₹60.04 Cr	₹49.26 Cr	+21.9%
Profit after tax	₹51.15 Cr	₹44.73 Cr	+14.4%
EBITDA margin	33.6%	32.5%	+1.1 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.